News 16 Gen 2023 Geneva start-up STALICLA signs exclusive in-licensing agreement with Novartis STALICLA has acquired global rights for Novartis' drug candidate mavoglurant, a treatment for substance-use disorders and neurodevelopmental diso...
News 23 Nov 2022 Geneva biopharma ObsEva sells its Ebopiprant license for up to USD 113 million Women's and reproductive health specialist ObsEva has announced the sale of its license for ebopiprant to California-based biotech company Xoma f...
News 26 Mag 2023 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...
News 13 Feb 2023 Hôpital de La Tour will invest CHF 750 million to create a health campus in Geneva Leading private healthcare facility Hôpital de la Tour has entered into a CHF 750 million agreement to create a major health campus project to pr...
News 15 Nov 2022 Comet, Neuria and PMF-System win the Fribourg Innovation Award The canton of Fribourg has distinguished its most innovative companies. The Business Award went to Comet, the Start-up Award went to Neuria, and ...
News 19 Set 2022 OnlineDoctor wins Health-i Award OnlineDoctor has won the Health-i Award presented by Techniker Krankenkasse and the Handelsblatt Media Group in the Companies category. With this...
News 07 Nov 2022 Idiap and InflamAlps partner up to accelerate antibiotic research using artificial intelligence The result of a partnership between Valais-based pharma company InflamAlps and the Idiap institute, the ABRoad project aims to accelerate the sel...